Results 271 to 280 of about 89,572 (287)

Docetaxel

Reactions Weekly, 2014
openaire   +1 more source

PEG–PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy

Biomaterials, 2014
Lijuan Chen, Liwei Tan, Qian Zhao
exaly  

Inter-patient variability in docetaxel pharmacokinetics: A review

Cancer Treatment Reviews, 2015
Annemieke J M Nieuweboer, Ellen S De Morree, Anne-Joy M De Graan   +2 more
exaly  

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

Lancet, The, 2014
Edward B Garon, Tudor-Eliade Ciuleanu, OSCAR Arrieta   +2 more
exaly  

Docetaxel

Reactions Weekly, 2010
openaire   +2 more sources

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients

European Journal of Nuclear Medicine and Molecular Imaging, 2010
N Harry Hendrikse, Albert D Windhorst, Adriaan A Lammertsma   +2 more
exaly  

Phase II study of docetaxel re‐treatment in docetaxel‐pretreated castration‐resistant prostate cancer

BJU International, 2011
Giuseppe Di Lorenzo, Carlo Buonerba, Pasquale Rescigno   +2 more
exaly  

Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer

Annals of Oncology, 2007
F Priou, P Kerbrat, B Paule
exaly  

Docetaxel reintroduction in patients with metastatic castration‐resistant docetaxel‐sensitive prostate cancer: a retrospective multicentre study

BJU International, 2010
Christine Theodore, Frank Priou, Philippe Beuzeboc   +2 more
exaly  

Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial

Annals of Oncology, 2006
CARLOS Camps, B Massutí, I Maestú
exaly